Tel.: +34 91 736 2385
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name


WFH 2016 World Congress


24-28 July 2016 Orlando
Discussion forum - WFH 2016 World Congress
    Topic - Hemostasis tests and assays

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
 Thread / Poster  Author  Replies  Last reply
A validated patient-specific numerical model of thrombin generation for the management of hemophilia  Brigitte TARDY 1      7/20/2016 2:51:00 PM  
Thrombin generation assay triggered with tissue factor or factor XIa in patients with severe haemophilia A  Hassan Naeem 1      7/7/2016 7:54:00 PM  
Enhancing appropriate utilization of coagulation tests  Michelle Sholzberg 1      7/7/2016 6:11:00 PM  
Application of global coagulation assays in Hemophilia B patients to evaluate the hemostatic potential in baseline conditions and after FIX concentrate administration.  Cristina Santoro 1      7/7/2016 5:52:00 PM  
Endogenous thrombin generation potential: an added value parameter to individualize prophylaxis treatment in pediatric hemophilic patients?  Phu-Quoc L 1      7/7/2016 4:18:00 PM  
Clinical application of rotational thromboelastometry (ROTEM) in the diagnostic work-out of thrombocytopenia  Adela Gwozdowska 1      7/6/2016 7:49:00 PM  
Thromboelastography may help to define haemostatic safety zones for the practice of sport in patients with severe haemophilia A  Ihosvany Fernández Bello 1      7/6/2016 6:24:00 PM  
Bleeding Score: normal values for healthy young adults  Karina Meijer 1      7/6/2016 4:29:00 PM  
Role of bleeding score and laboratory testing in women with menorrhagia to identify inherited bleeding disorders: the experience of a tertiary care hospital in South India  Annamma Joseph 1      7/6/2016 7:41:00 AM  
Activated partial thromboplastin time (APTT) of persons with haemophilia A can serve as a surrogate marker of their factor VIII activity  Teruhisa Fujii 1      7/6/2016 2:16:00 AM  
Heat treated Bethesda assay in the monitoring of acquired haemophilia A  Annette Bowyer 1      7/5/2016 1:29:00 PM  
Evaluation of the Sebia Hydragel von Willebrand factor (VWF) assay compared to an in-house agarose gel electrophoresis method for VWF multimer analysis  Karen Goodfellow 1      7/4/2016 4:55:00 PM  
Postoperative TGA monitoring of haemostasis of haemophilia patients with inhibitor (Second report)  fujihiko minamoto 1      4/30/2016 9:50:00 AM  

Most viewed poster for this congress
Poster: 13
Visits: 590
Title: Algorithmic evidence-based phenotype screening and collaborative approach to attacking symptoms of nonadherence in patients with bleeding disorders
Authors: Jay Bryant-Wimp , Jay Bryant-Wimp, RPh
Centre: Integrite Solutions

Poster most viewed in this topic
Poster: 69
Visits: 55
Title: Heat treated Bethesda assay in the monitoring of acquired haemophilia A
Authors: Annette Bowyer , Annette Bowyer
Centre: Coagulation dept, Royal Hallamshire Hospital, Sheffield


Logo Draft
Logo Cert